Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.

TSXV:TELO - Post by User

Telo Genomics Corp

Bullboard Posts

Comment by Loudermilkon Jan 03, 2018 10:06pm

201 Views

Post# 27276705

RE:3DS in 2018

I took a position during tax loss season after having DXD on my #watchlist since May. They've had a rough start but their unique diagnostic tech is disruptive to say the least. I'm expecting 2018 to be very strong for the company and honestly anything under $0.30 is essentially a fire sale going forward. It's a bull's market out there.

Bullboard Posts

Get a better understanding of the psychology of options trading